. 2013 Mar 15;13:120. doi: 10.1186/1471-2407-13-120
Copyright ©2013 Clarke et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1.
Study design. Bev = bevacizumab. PD = progressive disease.